跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 608 条关于
“AlloSeq cfDNA”
全部
608
临床试验
492
药物
7
机构
2
资讯
107
去年
CareDx's AlloSeq cfDNA Test Shows Strong Performance in Large European Kidney Transplant Study
上个月
Donor-Derived Cell-Free DNA Emerges as Leading Biomarker in Kidney Transplant Rejection Surveillance, Market to Reach $3.98 Billion by 2036
6个月前
CareDx Launches VANTx AI Platform for Transplant Data Analytics and Announces $170M Lab Products Divestiture
去年
Aqtual Raises $31 Million to Advance Novel cfDNA Platform for Rheumatoid Arthritis Therapy Prediction
3个月前
HPV cfDNA Demonstrates 95% Sensitivity for Detecting HPV-Driven Oropharyngeal Cancer and Predicts Recurrence Months Before Imaging
上个月
Renew Biotechnologies Publishes Proof-of-Concept Study on Neuron-Derived cfDNA Methylation Signatures for Alzheimer's, Parkinson's, and ALS
3个月前
CareDx Showcases AlloSure dd-cfDNA as Emerging Clinical Endpoint Across 30+ Abstracts at ATC 2026
上个月
Tagomics launches LiquiPath, a first-in-class cfDNA blood test for multi-organ drug safety monitoring
5个月前
DELFI Diagnostics Presents Five Studies on AI-Driven cfDNA Platform for Cancer Detection and Monitoring at AACR 2026
去年
DELFI Diagnostics and Incendia Therapeutics Collaborate on Phase 1 Trial Using Novel cfDNA Monitoring Assay
第 1 页,共 11 页
上一页
下一页